Mesoblast Limited

Analyst Reports

2011-November-15	MSB Releases Final Phase II Cardiac Trial Data, The Study Achieved its Primary Endpoint - We Await the Start of a Phase III Clinical Trial - A Report Prepared by Nomura Equity Research (in PDF)
2011-November-15	Mesoblast (MSB) - Phase II Success in Heart Failure - A Report Prepared by Bell Potter Securities Limited (in PDF)
2011-November-3	Teva Comments on MSB's Pipeline, First Look, Breaking News, Market Events and Company Announcements - A Report Prepared by Nomura Equity Research (in PDF)
2011-November-1	Mesoblast Ltd (MSB) - We Have Seen the Future, and it Works - A Report Prepared by Bell Potter Securities Limited (in PDF)
2011-September-30	Mesoblast (MSB) - Key Manufacturing Plank in Place - A Report Prepared by Lodge Partners Research (in PDF)
2011-September-27	MSB and Lonza Ink Cell Manufacturing Deal, Further Validation of MSB's Platform Technology, in Our View - A Report Prepared by Nomura Equity Research (in PDF)
2011-September-27	Mesoblast Ltd (MSB) - The Heart of the Matter - A Report Prepared by Bell Potter Securities Limited (in PDF)
2011-September-1	Mesoblast Ltd (MSB) - Expanding Boundaries - A Report Prepared by Lodge Partners Research (in PDF)
2011-August-26	Mesoblast - Affirms Strategy and Direction - A Bioshares Report Prepared by Blake Industry & Market Analysis (in PDF)
2011-August-24	Mesoblast (MSB) - The Heart of the Matter - A Report Prepared by Bell Potter Securities Limited (in PDF)
2011-August-24	FY11 - A Year of Transformation, MSB Continues to Find New Opportunities for its Platform Technology - A Report Prepared by Nomura Equity Research (in PDF)
2011-July-7	Announces Start of Phase 3 Trial in Transplant - Beginning of Phase III Trial Further De-risks the Business - A Report Prepared by Nomura Equity Research (in PDF)
2011-June-14	MSB to Start Phase 3 Clinical Trial of its Stem Cell Product for Bone Marrow Transplantation - A Report Prepared by Nomura Equity Research (in PDF)
2011-June-9	MSB will Start a Phase IIb Trial in Angina - Opens up a Market Dominated by Cardiac Stents - A Report Prepared by Nomura Equity Research (in PDF)
2011-May-24	Granted Patents Over Stem Cells from Multiple Sources - A Report Prepared by Nomura Equity Research (in PDF)
2011-May-3	Closing in for a Phase 3 Trial - A Report Prepared by Nomura Equity Research (in PDF)
2011-April-29	Mesoblast - Full Steam Ahead - A Bioshares Report Prepared by Blake Industry & Market Analysis (in PDF)
2011-March-31	The Canadians Create a Buying Opportunity - A Report Prepared by Southern Cross Equities (in PDF)
2011-March-3	The Stem Cell Opportunity in 2011 - A Report Prepared by Southern Cross Equities (in PDF)

DISCLAIMER: Any analyst or research report hyperlinked from this page contains only the view and opinion of those who prepared it and does not in any way represent the views of irasia.com. irasia.com has no control over any part of the contents of such report, and does not endorse or will take no responsibility for any aspects of the report and its contents. irasia.com will not be liable for any claims of any nature arising from or in connection with the report.